Pharmacy-Based Point-of-Care Test & Treat Certification Program

Course overview

Upon completion of the activity, pharmacists will be able to: Identify opportunities for pharmacists to utilize testing or screening for and the treatment of minor, nonchronic health conditions within the framework of an established written protocol with a supervising physician; Summarize the Clinical Laboratory Improvement Amendments CLIA as they pertain to pharmacy point-of-care testing POCT; Summarize the pathophysiology, clinical presentation, nonpharmacologic treatment, pharmacologic treatment, patient counseling and special population s considerations of the following disease states or conditions: Influenza, Streptococcus, Minor uncomplicated infections such as Herpes Simples Labialis, Cold Sores, Fever Blisters, and Uncomplicated Cystitis; Summarize the pathophysiology, clinical presentation, nonpharmacologic treatment, pharmacologic treatment, patient counseling and special population s considerations of the following disease states or conditions: Skin Conditions: Xerosis and Atopic Dermatitis; Scaley Dermatosis; Contact Dermatitis; Insect Stings and Bites; Lice; Acne; Minor Burns and Wounds; Fungal Skin Infections; Explain the pathophysiology, clinical presentation, nonpharmacologic treatment, pharmacologic treatment, patient counseling and special population s considerations of the following disease states: Other Respiratory infections e.g., Respiratory Syncytial Virus, Coronaviruses HIV - PrEP and PEP Hepatitis C Virus Sexually Transmitted Infections e.g. syphilis, chlamydia, and gonorrhea Conjunctivitis Helicobacter pylori Lyme Disease Infectious mononucleosis Define and summarize antimicrobial stewardship; Identify the role and responsibilities of state and local health departments, especially as they relate to disease surveillance and reporting; Describe how to implement testing or screening for and minor treatment of minor nonchronic health conditions services in your practice; Discuss the required components in Florida law for protocol development; Demonstrate the procedures for conducting a systematic physical assessment and identify normal and critical findings; Demonstrate the technique involved for the specimen collection types discussed; Develop a written protocol that includes all legally required components for legally authorized disease states and appropriate lab testing required.